M. R. Hilleman

1.8k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

M. R. Hilleman is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, M. R. Hilleman has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Infectious Diseases and 7 papers in Hepatology. Recurrent topics in M. R. Hilleman's work include Hepatitis B Virus Studies (9 papers), Viral gastroenteritis research and epidemiology (7 papers) and Hepatitis Viruses Studies and Epidemiology (7 papers). M. R. Hilleman is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Viral gastroenteritis research and epidemiology (7 papers) and Hepatitis Viruses Studies and Epidemiology (7 papers). M. R. Hilleman collaborates with scholars based in United States. M. R. Hilleman's co-authors include W. J. McAleer, William J. Miller, Eugene B. Buynak, D. Eugene Wampler, Robert Z. Maigetter, P. J. Provost, V. M. Villarejos, O. L. Ittensohn, A. A. Tytell and G. P. Lampson and has published in prestigious journals such as Nature, The Journal of Infectious Diseases and Experimental Biology and Medicine.

In The Last Decade

M. R. Hilleman

24 papers receiving 1.1k citations

Hit Papers

Human hepatitis B vaccine from recombinant yeast 1984 2026 1998 2012 1984 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. R. Hilleman United States 17 719 457 453 278 254 25 1.3k
Mark Berninger United States 9 555 0.8× 258 0.6× 343 0.8× 427 1.5× 85 0.3× 11 1.3k
Hai Yu China 20 561 0.8× 359 0.8× 433 1.0× 421 1.5× 212 0.8× 64 1.4k
Ming Qiao Australia 19 554 0.8× 427 0.9× 423 0.9× 160 0.6× 122 0.5× 36 1.1k
Morag Ferguson United Kingdom 19 352 0.5× 95 0.2× 377 0.8× 224 0.8× 117 0.5× 32 947
Hiroko Miyamoto Japan 21 683 0.9× 135 0.3× 930 2.1× 207 0.7× 146 0.6× 54 1.4k
Nicole Chenciner France 16 351 0.5× 76 0.2× 266 0.6× 222 0.8× 257 1.0× 27 886
Isao Fuke Japan 12 853 1.2× 1.0k 2.3× 412 0.9× 284 1.0× 78 0.3× 17 1.6k
Thomas J. Chambers United States 22 526 0.7× 397 0.9× 2.0k 4.5× 252 0.9× 189 0.7× 33 3.2k
Gonzalo Moratorio Uruguay 21 248 0.3× 139 0.3× 522 1.2× 365 1.3× 174 0.7× 51 1.2k
Masahiro Niikura Japan 27 997 1.4× 67 0.1× 691 1.5× 400 1.4× 269 1.1× 88 2.0k

Countries citing papers authored by M. R. Hilleman

Since Specialization
Citations

This map shows the geographic impact of M. R. Hilleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. R. Hilleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. R. Hilleman more than expected).

Fields of papers citing papers by M. R. Hilleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. R. Hilleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. R. Hilleman. The network helps show where M. R. Hilleman may publish in the future.

Co-authorship network of co-authors of M. R. Hilleman

This figure shows the co-authorship network connecting the top 25 collaborators of M. R. Hilleman. A scholar is included among the top collaborators of M. R. Hilleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. R. Hilleman. M. R. Hilleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hilleman, M. R.. (1985). Newer Directions in Vaccine Development and Utilization. The Journal of Infectious Diseases. 151(3). 407–419. 21 indexed citations
3.
McAleer, W. J., Eugene B. Buynak, Robert Z. Maigetter, et al.. (1984). Human hepatitis B vaccine from recombinant yeast. Nature. 307(5947). 178–180. 529 indexed citations breakdown →
4.
Hurni, William M., et al.. (1984). Viral Enhancement and Interference Induced in Cell Culture by Hepatitis A Virus: Application to Quantitative Assays for Hepatitis A Virus. Experimental Biology and Medicine. 175(1). 84–87. 1 indexed citations
5.
McAleer, W. J., Henry Z. Markus, F. James Bailey, et al.. (1983). Production of purified hepatitis B surface antigen from Alexander hepatoma cells grown in artificial capillary units. Journal of Virological Methods. 7(5-6). 263–271. 16 indexed citations
6.
Provost, P. J., et al.. (1983). Studies in Chimpanzees of Live, Attenuated Hepatitis A Vaccine Candidates. Experimental Biology and Medicine. 172(3). 357–363. 49 indexed citations
7.
Provost, P. J., et al.. (1982). Progress toward a Live, Attenuated Human Hepatitis A Vaccine. Experimental Biology and Medicine. 170(1). 8–14. 51 indexed citations
8.
Buynak, Eugene B., et al.. (1980). Persistence of Antibody in Human Subjects for 7 to 10 Years following Administration of Combined Live Attenuated Measles, Mumps, and Rubella Virus Vaccines. Experimental Biology and Medicine. 165(2). 260–263. 43 indexed citations
9.
McLean, A. A., et al.. (1978). Live Respiratory Syncytial Virus Vaccine Administered Parenterally. Experimental Biology and Medicine. 157(4). 636–642. 26 indexed citations
10.
Martínez, D., Anjalie Field, Harvey Schwam, A. A. Tytell, & M. R. Hilleman. (1978). Failure of Thymopoietin, Ubiquitin and Synthetic Serum Thymic Factor to Restore Immunocompetence in T-Cell Deficient Mice. Experimental Biology and Medicine. 159(2). 195–200. 12 indexed citations
11.
Villarejos, V. M., P. J. Provost, O. L. Ittensohn, A. A. McLean, & M. R. Hilleman. (1976). Seroepidemiologic Investigations of Human Hepatitis Caused by A, B, and a Possible Third Virus. Experimental Biology and Medicine. 152(4). 524–528. 35 indexed citations
12.
Miller, William J., P. J. Provost, W. J. McAleer, et al.. (1975). Specific Immune Adherence Assay for Human Hepatitis A Antibody. Application to Diagnostic and Epidemiologic Investigations. Experimental Biology and Medicine. 149(1). 254–261. 140 indexed citations
13.
Lampson, G. P., M. M. Nemes, Anjalie Field, A. A. Tytell, & M. R. Hilleman. (1972). The Effect of Altering the Size of Poly C on the Toxicity and Antigenicity of Poly I:C. Experimental Biology and Medicine. 141(3). 1068–1072. 9 indexed citations
14.
Tytell, A. A., et al.. (1971). In Vitro Safety Assessment of Double-Stranded Polynucleotides Poly I:C and Mu-9. Experimental Biology and Medicine. 137(4). 1194–1198. 4 indexed citations
15.
Lampson, G. P., Anjalie Field, A. A. Tytell, M. M. Nemes, & M. R. Hilleman. (1970). Relationship of Molecular Size of rIn:rCn (Poly I:C) to Induction of Interferon and Host Resistance. Experimental Biology and Medicine. 135(3). 911–916. 21 indexed citations
16.
Hilleman, M. R.. (1970). Prospects for the Use of Double-Stranded Ribonucleic Acid (Poly I:C) Inducers in Man. The Journal of Infectious Diseases. 121(2). 196–211. 48 indexed citations
17.
Nemes, M. M., A. A. Tytell, G. P. Lampson, Anjalie Field, & M. R. Hilleman. (1969). Inducers of Interferon and Host Resistance VI. Antiviral Efficacy of Poly I:C in Animal Models. Experimental Biology and Medicine. 132(2). 776–783. 63 indexed citations
18.
Nemes, M. M., A. A. Tytell, G. P. Lampson, Anjalie Field, & M. R. Hilleman. (1969). Inducers of Interferon and Host Resistance VII. Antiviral Efficacy of Double-Stranded RNA of Natural Origin. Experimental Biology and Medicine. 132(2). 784–789. 22 indexed citations
19.
Hilleman, M. R.. (1958). Status Report on Adenoviruses and Asian Influenza. Military Medicine. 123(1). 23–30. 4 indexed citations
20.
Binn, Leonard N. & M. R. Hilleman. (1958). Detection of Poliovirus I in Monkey Kidney Cultures Inoculated with Overwhelming Dose of Adenovirus 4. The Journal of Infectious Diseases. 103(2). 127–128.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026